PATIENTS FIRST
LIVE

Add to watchlist:

No watchlists yet
View on USPTO

PATIENTS FIRST Trademark

Serial Number: 99492717

PATIENTS FIRST is a trademark filed by Hercules Pharmaceuticals, Inc. on November 12, 2025. The trademark is classified under Class 5 (Pharmaceuticals), Class 41 (Education & Entertainment), Class 42 (Computer & Scientific), Class 44 (Medical Services), Class 35 (Advertising & Business). The application is currently pending registration.

Owner Contact Info

Hercules Pharmaceuticals, Inc.

27 Seaview Boulevard
Port Washington, NY 11050

Entity Type: 03

Trademark Details

Filing Date

November 12, 2025

Registration Date

Not Registered

Goods & Services

Wholesale distribution in the nature of wholesale distributorships featuring prescription and non-prescription pharmaceutical products, medical devices, and other FDA regulated products; wholesale ordering services in the field of prescription and non-prescription pharmaceutical preparations, dietary supplements, and medical devices; wholesale services by direct solicitation by sales agents in the field of prescription and non-prescription pharmaceutical preparations, dietary supplements, and medical devices; on-line wholesale store services featuring prescription and non-prescription pharmaceutical preparations, dietary supplements, and medical devices.

Providing health information to pharmacies and healthcare providers in the field of medication adherence, safe use of pharmaceuticals, and patient safety

Providing educational services, namely, conducting information sessions and training programs in the field of pharmaceutical wholesaling and distribution best practices, patient safety, and medication adherence

FDA-regulated pharmaceutical products including brand medicine, generic medicine, biologics and biosimilars, orphan drugs, over-the-counter drugs, controlled substances, medical devices, vitamins, and supplements for the treatment of cardiovascular diseases; neurological disorders; psychiatric and psychological conditions; infectious diseases including viral, bacterial, and fungal infections; HIV and hepatitis; oncological diseases and malignancies; dermatological conditions; pulmonary and respiratory disorders; nephrological diseases; gastrointestinal and hepatic conditions; hematologic disorders; reproductive and fertility-related conditions; immunological and allergic conditions; endocrine and metabolic disorders including diabetes; musculoskeletal and orthopedic conditions; ophthalmologic disorders; transplant-related conditions and post-operative complications; as well as for the management of pain and other chronic or acute medical conditions.

Quality control for recipients in the field of pharmaceutical wholesale distribution

Filing History

NOTIFICATION OF NON-FINAL ACTION E-MAILED
Apr 1, 2026 GNRN
NON-FINAL ACTION E-MAILED
Apr 1, 2026 GNRT
NON-FINAL ACTION WRITTEN
Apr 1, 2026 CNRT
ASSIGNED TO EXAMINER
Mar 22, 2026 DOCK
TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Dec 18, 2025 EWAF
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Dec 18, 2025 TCCA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Dec 18, 2025 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Dec 18, 2025 REAP
APPLICATION FILING RECEIPT MAILED
Nov 12, 2025 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Nov 12, 2025 NWOS
NEW APPLICATION ENTERED
Nov 12, 2025 NWAP